Amanote Research
Register
Sign In
Phosphodiesterase-4 (PDE-4)
Science-Business eXchange
doi 10.1038/scibx.2010.96
Full Text
Open PDF
Abstract
Available in
full text
Date
January 1, 2010
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
Synthetic Studies on Selective Type 4 Phosphodiesterase (PDE 4) Inhibitors. 1. Structure–Activity Relationships and Pharmacological Evaluation of 1,8-Naphthyridin-2(1h)-One Derivatives
Chemical and Pharmaceutical Bulletin
Medicine
Drug Discovery
Chemistry
The Dunce cAMP Phosphodiesterase PDE-4 Negatively Regulates G S-Dependent and G S-Independent cAMP Pools in the Caenorhabditis Elegans Synaptic Signaling Network
Genetics
Genetics
Pharmacological Profile of GPD-1116, an Inhibitor of Phosphodiesterase 4
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis
Rheumatology and Therapy
Targeted Inhibition of Cyclic AMP Phosphodiesterase-4 Promotes Brain Tumor Regression
Clinical Cancer Research
Cancer Research
Oncology
ERK Regulation of Phosphodiesterase 4 Enhances Dopamine-Stimulated AMPA Receptor Membrane Insertion
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
The Unrecognized Effects of Phosphodiesterase 4 on Epithelial Cells in Pulmonary Inflammation
PLoS ONE
Multidisciplinary
Reduced Airway Hyperresponsiveness by Phosphodiesterase 3 and 4 Inhibitors in Guinea-Pigs
Mediators of Inflammation
Immunology
Cell Biology
Involvement of Type 4 cAMP-Phosphodiesterase in the Myogenic Differentiation of L6 Cells
Molecular Biology of the Cell
Cell Biology
Molecular Biology
